The following is a summary of “RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing,” published in the ...

Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

With the cooler days comes RSV, a respiratory virus that puts babies at risk for serious disease and sends thousands of Utah children to the ...

The drug was 88% effective against the need for medical attention among those in their second respiratory virus season.

Nearly all children get infected with respiratory syncytial virus, more commonly known as RSV, at least once by the time they ...

Infant deaths during a trial of a medicine that protects against respiratory syncytial virus were caused by unrelated factors ...

Thanksgiving is a little over a week away, winter holidays will follow closely behind, and the Washington State Department of ...

Some Alberta doctors are calling on the provincial government to make an injection designed to protect newborns from severe ...

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

As of last year, RSV vaccination with Abrysvo has been recommended for pregnant women in the United States from 32 to 36 ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...